Skip to main content
. 2021 Jan 7;41(1):BSR20202444. doi: 10.1042/BSR20202444

Figure 5. Risk score analysis of the six-lncRNA signature in LUAD patients.

Figure 5

Risk score analysis of the differentially expressed lncRNA signature of LUAD in the training cohort (A) and the testing cohort (B). Risk score of lncRNA signature (top); Survival status and duration of cases (middle); Low-score and high-score groups for the six lncRNAs (bottom).